World AMR Awareness Week (WAAW), occurring 18-24 November every year, is a global awareness campaign that aims to improve understanding of antimicrobial resistance (AMR). It acts as a platform to share resources and evidence of best practice among One Health...
Posts by admin
World Patient Safety Day 2024 – How the Q-POC Platform Supports Patient Safety
World Patient Safety Day is an annual global awareness campaign, led by the World Health Organization (WHO), that emphasises the importance of improving healthcare practices to prevent harm to patients. World Patient Safety Day 2024 The theme of World Patient Safety...
A guide to the UN General Assembly High-Level Meeting on Antimicrobial Resistance 2024
Antimicrobial resistance: A global threat Antimicrobial resistance (AMR) occurs when pathogens (e.g. bacteria, viruses, fungi, and parasites) that cause infections no longer respond to the drugs used to treat them, an issue that poses a significant global public...
The Next Pandemic: Q-POC and Disease X
The recent COVID-19 pandemic was a humanitarian and economic disaster, directly contributing to at least three million deaths and costing as much as US$15.8 trillion1. The pandemic also had many indirect effects on our health, with routine operations and medical...
Microarray-Based Technologies in Molecular Diagnostics: A Review
Microarray technologies have the potential to add significant value to the field of clinical diagnostics. This powerful technology is high-throughput and sensitive, allowing for the rapid screening of many genetic markers in parallel. In this blog post, we explore how...
QuantuMDx awarded Outstanding Achievement Award at Medilink Healthcare Business Awards 2024
QuantuMDx are delighted to have been awarded the Outstanding Achievement Award sponsored by Abacus at the 2024 Medilink Healthcare Business Awards. This award was for the Q-POC point of care PCR platform. It was a great evening with some truly inspiring stories....
Regulatory Challenges in Molecular Diagnostics: An Overview
Working in Regulatory Affairs is never boring. We’re in a space where the ground is shifting beneath our feet and not just little tremors - the whole landscape is in flux. The changes are greatest in Great Britain and Europe but, the advantage is that these things...
The Benefits of Rapid Diagnostics at the Point of Care
Throughout human history, infectious diseases have been a major cause of suffering and mortality. Remarkably, it was once suggested that half of all humans who have ever lived have been killed by malaria [1]. Equally incredibly, this may represent the tip of the...
Great North Research Conference
QMDx attended the Great North Research Conference recently. This was the first conference organised by NIHR to bring together academics and commercial companies within the North of England, to celebrate their achievements and showcase their expertise to allow for...
Transforming Point-of-Care Molecular Diagnostics at GIS23 Summit
We are delighted to share another achievement for QuantuMDx, and the North-East, within the molecular diagnostics space. On November 27th, 2023, QuantuMDx was invited to participate in the Global Investment Summit 2023 at Hampton Court Palace. This exclusive event...
Multiplex PCR and Infectious Disease Diagnosis
Polymerase chain reaction (PCR) is a widely-used technique in molecular biology. Thanks to the COVID-19 pandemic, the general public has become far more aware of PCR and its use in molecular diagnostics. In this blog, we will describe the information that can be...
Diagnosing Influenza at the Point of Care
Influenza, or ‘flu', is a common respiratory infection usually associated with a seasonal increase during the winter months - often referred to as 'flu season'. There are estimated to be around 1 billion cases annually, with more severe symptoms for those at higher...
The Clinical Impact of Rapid Multiplex PCR Testing Respiratory Viruses
As we enter the long anticipated period of summer holidays, it may seem premature to be thinking about winter planning but this is exactly what our colleagues in the NHS are doing. Through the months of October to March, winter planning aims to boost capacity and...
The Rise of Multi-Drug Resistant Gonorrhoea
Earlier this year (19 January 2023), the United States reported its first two cases of gonorrhoeal infection that had a reduced likelihood of responding to antibiotics. Even though gonorrhoeal infections are rarely life-threatening, this short post describes...













